Publications
Detailed Information
Fragile maintenance of allograft tolerance induced by lymphocyte sequestration and co-stimulation blockade
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jin, Jizhe | - |
dc.contributor.author | Yang, Seung Hee | - |
dc.contributor.author | Park, Junghwan | - |
dc.contributor.author | Lee, Chungsik | - |
dc.contributor.author | Kim, Sun Moon | - |
dc.contributor.author | Kim, Yon Su | - |
dc.contributor.author | Lee, Jungpyo | - |
dc.date.accessioned | 2012-05-24T02:38:17Z | - |
dc.date.available | 2012-05-24T02:38:17Z | - |
dc.date.issued | 2009-09 | - |
dc.identifier.citation | TRANSPLANT IMMUNOLOGY; Vol.21 4; 221-227 | ko_KR |
dc.identifier.issn | 0966-3274 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76390 | - |
dc.description.abstract | The induction of long-term graft survival has been a goal for the last decade. Nevertheless, the issues of stable maintenance of allograft have not yet been evaluated thoroughly. Here, we studied new approaches for induction of tolerance by lymphocyte sequestration (FrY720) and co-stimulatory blockade (MRI) in skin graft model (DBA/2 to BALB/c), thus evaluating the mechanisms incorporated into the maintenance of allograft in proper function. IFTY720 + MR1 treatment significantly prolonged graft survival than single agent treatment did, and induced long-term graft survival in 60% of recipients expressing the up-regulation of IL-4 and FoxP3. To assess the stability of graft maintenance, we performed the second transplantation on recipients that had shown long-term graft survival. While recipients accepted the second graft from the same strain of first donor, the recipients not only rejected the third-party skin (C57BL/6) promptly but also rejected the first graft soon after the third-party skin was transplanted. The expression patterns of IL-4 and FoxP3 were changed according to the strains of second graft in lymph nodes and in the first graft. T(reg) cells from tolerant recipients effectively suppressed allo-antigen driven T cell proliferation, but T(reg) cells from recipients primed with third-party antigen had significantly hampered suppressive capacity against previously tolerant antigens. Our data indicate that the combination treatment provides effective tool for the induction of long-term graft survival, and the maintenance of allograft in proper function is an actively regulated process. (C) 2009 Elsevier B.V. All rights reserved. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ELSEVIER SCIENCE BV | ko_KR |
dc.subject | Immunoregulation | ko_KR |
dc.subject | Lymphocyte sequestration | ko_KR |
dc.subject | Co-stimulation blockade | ko_KR |
dc.subject | Long-term graft survival | ko_KR |
dc.title | Fragile maintenance of allograft tolerance induced by lymphocyte sequestration and co-stimulation blockade | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 양승희 | - |
dc.contributor.AlternativeAuthor | 박정환 | - |
dc.contributor.AlternativeAuthor | 이정식 | - |
dc.contributor.AlternativeAuthor | 이정표 | - |
dc.contributor.AlternativeAuthor | 김선문 | - |
dc.contributor.AlternativeAuthor | 김연수 | - |
dc.identifier.doi | 10.1016/j.trim.2009.06.001 | - |
dc.citation.journaltitle | TRANSPLANT IMMUNOLOGY | - |
dc.description.citedreference | Guo K, 2008, TRANSPLANTATION, V85, P93, DOI 10.1097/01.tp.0000296061.71662.76 | - |
dc.description.citedreference | Jee Y, 2007, CLIN IMMUNOL, V125, P34, DOI 10.1016/j.clim.2007.05.020 | - |
dc.description.citedreference | Boschiero L, 2007, TRANSPL P, V39, P2013 | - |
dc.description.citedreference | Kang SM, 2007, AM J TRANSPLANT, V7, P1457, DOI 10.1111/j.1600-6143.2007.01829.x | - |
dc.description.citedreference | Plain KM, 2007, TRANSPLANTATION, V83, P764, DOI 10.1097/01.tp.0000256326.11647.2e | - |
dc.description.citedreference | Jiang SP, 2006, TRANSPLANTATION, V82, P1738, DOI 10.1097/01.tp.0000244932.29542.9e | - |
dc.description.citedreference | Wang Y, 2006, AM J TRANSPLANT, V6, P2851, DOI 10.1111/j.1600-6143.2006.01550.x | - |
dc.description.citedreference | Chattopadhyay K, 2006, J IMMUNOL, V177, P3920 | - |
dc.description.citedreference | Rudensky AY, 2006, CELL, V126, P253, DOI 10.1016/j.cell.2006.07.005 | - |
dc.description.citedreference | Zhai YA, 2006, J IMMUNOL, V176, P5988 | - |
dc.description.citedreference | Kaplan B, 2006, AM J KIDNEY DIS, V47, pS52, DOI 10.1053/j.ajkd.2005.12.044 | - |
dc.description.citedreference | Isoyama N, 2006, TRANSPL IMMUNOL, V15, P265, DOI 10.1016/j.trim.2006.02.004 | - |
dc.description.citedreference | CHIBA K, 2006, CELL MOL IMMUNOL, V3, P11 | - |
dc.description.citedreference | Sawicka E, 2005, J IMMUNOL, V175, P7973 | - |
dc.description.citedreference | Wing K, 2005, IMMUNOLOGY, V115, P516, DOI 10.1111/j.1365-2567.2005.02186.x | - |
dc.description.citedreference | Wang WG, 2005, FASEB J, V19, P1731, DOI 10.1096/fj.05-3730fje | - |
dc.description.citedreference | Yan S, 2005, TRANSPLANTATION, V79, P1703, DOI 10.1097/01.TP.0000164501.65352.39 | - |
dc.description.citedreference | Karim M, 2005, BLOOD, V105, P4871, DOI 10.1182/blood-2004-10-3888 | - |
dc.description.citedreference | Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179 | - |
dc.description.citedreference | Walsh PT, 2004, J CLIN INVEST, V114, P1398, DOI 10.1172/JCI200423238 | - |
dc.description.citedreference | Tanchot C, 2004, J IMMUNOL, V172, P4285 | - |
dc.description.citedreference | van Maurik A, 2004, J IMMUNOL, V172, P2163 | - |
dc.description.citedreference | Abdi R, 2004, J IMMUNOL, V172, P767 | - |
dc.description.citedreference | Wang MH, 2003, ACTA PHARMACOL SIN, V24, P847 | - |
dc.description.citedreference | Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904 | - |
dc.description.citedreference | Xie JH, 2003, J IMMUNOL, V170, P3662 | - |
dc.description.citedreference | Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490 | - |
dc.description.citedreference | Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C220176200 | - |
dc.description.citedreference | Hori S, 2002, P NATL ACAD SCI USA, V99, P8213, DOI 10.1073/pnas.122224799 | - |
dc.description.citedreference | Weiner HL, 2001, IMMUNOL REV, V182, P207 | - |
dc.description.citedreference | He XY, 2001, TRANSPLANT P, V33, P703 | - |
dc.description.citedreference | WONDIMU B, 2001, INT J PAEDIATR DENT, V11, P424 | - |
dc.description.citedreference | POHANKA E, 2001, CURR OPIN UROL, V11, P143 | - |
dc.description.citedreference | Thornton AM, 2000, J IMMUNOL, V164, P183 | - |
dc.description.citedreference | Fujiwara I, 1999, TRANSPLANT P, V31, P2831 | - |
dc.description.citedreference | Hwang MW, 1999, CIRCULATION, V100, P1322 | - |
dc.description.citedreference | Itoh M, 1999, J IMMUNOL, V162, P5317 | - |
dc.description.citedreference | Sayegh MH, 1998, NEW ENGL J MED, V338, P1813 | - |
dc.description.citedreference | Onodera K, 1997, J IMMUNOL, V158, P1572 | - |
dc.description.citedreference | MACDONALD HR, 1988, J EXP MED, V167, P2005 | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.